Standard Drug Discovery and Development

$1 to $2 billion

Cost of a new drug development

10 to 15 years

To develop a new drug

1:10k

Success rate

We can reduce those numbers to

$250k – $50M

Cost of a new drug development

4 to 5 years

To develop a new drug

3:10

Success rate

OUR APPROACH

Artificial Intelligence

Propietary Databases of Chemical Structures

Scientific Expertise

Learn about our Unique Approach

Our Directions of Work

Proprietary pipeline

Proprietary pipeline

PARTNERSHIP

Our performance indicators

12%

of our performed projects have
reached Clinical Phase 2

29%

of our projects have a positive
in vitro lead

We cooperate with

LATEST NEWS

Top Spanish Start-ups to follow in 2020
SOM Biotech is one of the Top Spanish Start-ups to follow in 2020
January 31, 2020

SOM Biotech is one of the Top Spanish Start-ups to follow in 2020 according to Sifted. Since its foundation in 2009, SOM Biotech stands out for its dynamism, its scientific rigor, and its innovative spirit. As an AI drug discovery company, SOM Biotech has developed more than 50 projects, has licensed ...

SOM Biotech achieves relevant advances in its pipeline leveraging on its proprietary AI based drug discovery technology SOM[AI]- PRO
January 28, 2020

SOM Biotech closes a remarkable year, achieving relevant advances in its drug development pipeline. Leveraging on its proprietary AI-based drug discovery technology SOMAI-PRO. According to Raul Insa – CEO of SOM Biotech – “ 2019 has been a great year, in which we have achieved major milestones in our pipeline ...

SOM Biotech at the Invest Securities Biomed Event
January 28, 2020

SOM Biotech attends the Invest Securities Biomed Event on January 28th in Paris. Raul Insa – CEO of SOM Biotech – participates in “one to one” meetings with international institutional investors. Therefore, according to Dr. Insa: “we will have the opportunity to share with qualified investors SOM´s future strategic growth ...

Biomedical companies rise 60 million in investment rounds – Press release EXPANSIÓN Catalunya
January 24, 2020

The Catalan Biotechnology and digital health companies dedicated to biomedicine and digital health captured 59.8 million euros in 2019 in financing rounds, 4.9% more than in 2018, when the investment volume reached 57 million, according to the ranking elaborated by EXPANSIÓN Catalunya. SOM Biotech is in third place on the ...

SOM Biotech at the JP Morgan Healthcare Conference and Biotech Showcase 2020
January 9, 2020

SOM Biotech will attend the JP Morgan Healthcare Conference and Biotech Showcase Conference on January 13rd -15th 2020 – in San Francisco, USA. Raul Insa – CEO and Maria Zimina – Business Development Manager of SOM Biotech – will be attending one-to-one meetings with qualified life science investors as well ...

SOM Biotech at the FDA Workshop
SOM Biotech attended the FDA Workshop
December 10, 2019

SOM Biotech attended the FDA Workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenge” on December 5th -6th– in Rockville, USA. The workshop aimed at exploring opportunities and challenges in assessing the safety and efficacy of repurposed drugs, as well as exploring several drug development pathways for treatments, with a specific ...

SOM Biotech at the 10th Drug Discovery Innovation Programme
November 29, 2019

SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight ...

SOM Biotech at the Clinical Trials Europe 2019 conference
November 27, 2019

SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams ...